IRMD vs NEM · P/E 51, rev $42.4M vs P/E 14, rev $13.43B
Iradimed Co (IRMD) versus Newmont Goldcorp Corp (NEM) — a side-by-side from cached financials, not a winner call.
Iradimed Co (IRMD) is a medical devices company listed on US.
Newmont Goldcorp Corp (NEM) is a gold company listed on NYSE.
Latest reported IRMD revenue for 2026-06-30 was $42.4M. Net income was $11.0M. Revenue was up 93.1% from 2026-03-31 to 2026-06-30. IRMD currently screens at market cap $1.19B and trailing P/E 50.9.
Latest reported NEM revenue for 2026-06-30 was $13.43B. Net income was $5.46B. Revenue was up 83.7% from 2026-03-31 to 2026-06-30. NEM currently screens at market cap $112.81B and trailing P/E 13.7.
IRMD currently screens at market cap $1.19B and trailing P/E 50.9. NEM currently screens at market cap $112.81B and trailing P/E 13.7.
Not investment advice. Open the IRMD and NEM stock pages for the full models.
Not investment advice.